Welcome to LookChem.com Sign In|Join Free

CAS

  • or

200283-08-5

Post Buying Request

200283-08-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

200283-08-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 200283-08-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,0,2,8 and 3 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 200283-08:
(8*2)+(7*0)+(6*0)+(5*2)+(4*8)+(3*3)+(2*0)+(1*8)=75
75 % 10 = 5
So 200283-08-5 is a valid CAS Registry Number.

200283-08-5Relevant articles and documents

Convenient synthesis of a galacturonic acid based macrocycle with potential copper-complexation ability

Allam, Anas,Dupont, Laurent,Behr, Jean-Bernard,Plantier-Royon, Richard

, p. 817 - 823 (2012)

A convenient approach to the construction of a galacturonic acid based macrocycle containing an amide group and a triazole ring has been achieved. The key step relies on the efficient formation of a 16-membered ring by a copper-catalysed intramolecular cycloaddition reaction applied to analkyne-azide galacturonate. Depending on the reaction conditions, the outcome of the 1,3-dipolar cycloaddition varied; the expected intramolecular 1,4-triazole was obtained as well as a C2-symmetric dimer in different ratios. A preliminary study of the complexation properties of this macrocycle towards CuII cations revealed the formation of cryptates in a 1:1 metal/ligand ratio. A galacturonic acid based macrocycle containing an amide group and a triazole ring has been synthesized by a procedure involving a copper-catalysed intramolecular cycloaddition reaction as the key step. The results of a preliminary study of the complexation properties of this macrocycle towards CuII cations are described. Copyright

COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS

-

Paragraph 00430, (2018/10/19)

The disclosure features novel lipids and compositions involving the same. Nanoparticle compositions include a novel lipid as well as additional lipids such as phospholipids, structural lipids, and PEG lipids. Nanoparticle compositions further including therapeutic and/or prophylactics such as RNA are useful in the delivery of therapeutic and/or prophylactics to mammalian cells or organs to, for example, regulate polypeptide, protein, or gene expression.

MACROCYCLIC TGF-BR2 KINASE INHIBITORS

-

Page/Page column 101, (2015/10/05)

The present invention relates to macrocyclic compounds and compositions containing said compounds acting as kinase inhibitors, in particular as inhibitors of Transforming Growth Factor beta Receptor 2 (TGF-β R2) and/or mutants thereof, for use in the diag

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 200283-08-5